Atlas Trials

Akamis Bio

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Akamis Bio

RecordFirmDate
NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer (NCT06459869)Akamis Bio2025-04-07
Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY) (NCT05165433)Akamis Bio2022-04-13
Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours (NCT05043714)Akamis Bio2021-12-01
A Study of NG-641 and Pembrolizumab in Squamous Cell Carcinoma of the Head and Neck (NCT04830592)Akamis Bio2021-11-04
First in Human Study With NG-641, a Tumour Selective Transgene Expressing Adenoviral Vector (NCT04053283)Akamis Bio2020-01-23
First in Human Study of NG-350A (an Oncolytic Adenoviral Vector Which Expresses an Anti-CD40 Antibody) (NCT03852511)Akamis Bio2019-02-19

Track Akamis Bio automatically

Every clearance here is in the API, with alerts when new ones post.